Verma S - Search Results

1

New markers of inflammation and endothelial cell activation: Part I.

Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. Szmitko PE, et al. Among authors: verma s. Circulation. 2003 Oct 21;108(16):1917-23. doi: 10.1161/01.CIR.0000089190.95415.9F. Circulation. 2003. PMID: 14568885 Review. No abstract available.

2

Transplantation of cryopreserved cardiomyocytes.

Yokomuro H, Li RK, Mickle DA, Weisel RD, Verma S, Yau TM. Yokomuro H, et al. Among authors: verma s. J Thorac Cardiovasc Surg. 2001 Jan;121(1):98-107. doi: 10.1067/mtc.2001.111418. J Thorac Cardiovasc Surg. 2001. PMID: 11135166 Free article.

3

Angiogenesis: protein, gene, or cell therapy?

Fedak PW, Verma S, Weisel RD, Mickle DA, Li RK. Fedak PW, et al. Among authors: verma s. Heart Surg Forum. 2001;4(4):301-4. Heart Surg Forum. 2001. PMID: 11827855 Review. No abstract available.

4

Fundamentals of endothelial function for the clinical cardiologist.

Verma S, Anderson TJ. Verma S, et al. Circulation. 2002 Feb 5;105(5):546-9. doi: 10.1161/hc0502.104540. Circulation. 2002. PMID: 11827916 Review. No abstract available.

5

L-arginine protects human heart cells from low-volume anoxia and reoxygenation.

Shiono N, Rao V, Weisel RD, Kawasaki M, Li RK, Mickle DA, Fedak PW, Tumiati LC, Ko L, Verma S. Shiono N, et al. Among authors: verma s. Am J Physiol Heart Circ Physiol. 2002 Mar;282(3):H805-15. doi: 10.1152/ajpheart.00594.2001. Am J Physiol Heart Circ Physiol. 2002. PMID: 11834473 Free article. Review.

6

The T-786-->C mutation in endothelial nitric oxide synthase is associated with hypertension.

Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, Jones C, Lonn E, Charbonneau F, Anderson TJ. Hyndman ME, et al. Among authors: verma s. Hypertension. 2002 Apr;39(4):919-22. doi: 10.1161/01.hyp.0000013703.07316.7f. Hypertension. 2002. PMID: 11967250

7

Endothelin blockade potentiates endothelial protective effects of ACE inhibitors in saphenous veins.

Ko L, Maitland A, Fedak PW, Dumont AS, Badiwala M, Lovren F, Triggle CR, Anderson TJ, Rao V, Verma S. Ko L, et al. Among authors: verma s. Ann Thorac Surg. 2002 Apr;73(4):1185-8. doi: 10.1016/s0003-4975(01)03605-0. Ann Thorac Surg. 2002. PMID: 11996261

8

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.

Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, Mickle DA. Verma S, et al. Circulation. 2002 Apr 23;105(16):1890-6. doi: 10.1161/01.cir.0000015126.83143.b4. Circulation. 2002. PMID: 11997273

9

Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function.

Hyndman ME, Verma S, Rosenfeld RJ, Anderson TJ, Parsons HG. Hyndman ME, et al. Among authors: verma s. Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2167-72. doi: 10.1152/ajpheart.00935.2001. Am J Physiol Heart Circ Physiol. 2002. PMID: 12003825 Free article.

10

Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability.

Pannirselvam M, Verma S, Anderson TJ, Triggle CR. Pannirselvam M, et al. Among authors: verma s. Br J Pharmacol. 2002 May;136(2):255-63. doi: 10.1038/sj.bjp.0704683. Br J Pharmacol. 2002. PMID: 12010774 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,411 results

Search Page